Inhibition of Bifidobacterium SP Isolated From Infants Feces Towards Adhesion of Salmonella Typhi on Balb/c Mice Enterocyte by Sukrama, I. D. (I) et al.
  
INHIBITION OF BIFIDOBACTERIUM sp ISOLATED FROM INFANTS FECES 
TOWARDS ADHESION OF SALMONELLA TYPHI ON BALB/c MICE ENTEROCYTE 
 
I D. M. Sukrama1, K. Sukardika2, Sumarno3, N. Mantik Astawa4 
 
1Postgraduate Program, Udayana University  
2Faculty of Medicine, Udayana University 
3Faculty of Medicine, Brawijaya University 




Diarrhea, up to the recent year remains a cause of high morbidity and mortality 
worldwide, especially in developing countries including Indonesia. Research concerning of 
management, prevention, and medication of the disease have been continually improved. The 
aim of this research is searching Bifidobacterium sp isolated from infants feces. This 
Bifidobacterium was then applied as an anti-adhesion of Salmonella typhi in the hope to gain a 
cure of diarrhea. This research employed two research designs, namely descriptive exploration 
and true experimental. Exploration was applied in order to obtain isolation and characterization 
of Bifidobacterium isolated from infants feces. Adherence ability of this Bifidobacterium sp 
towards Salmonella typhi adhesion on mice entherocyte was then carried out by applying 
Randomized Posttest-Only Control Group Design. In this research, average Bifidobacterium sp 
adhesion index of 1950 on entherocyte was obtained. In simple word, there are 19.5 
Bifidobacteria adhere to any single entherocyte cell. This adhesion index value is higher 
compare to Salmonella typhi adhesion of 1504. Conclusions that can be drawn from this research 
are the finding of Bifidobacterium sp isolated from infants feces. This Bifidobacterium sp has an 
ability to inhibit adhesion of Salmonella typhi on BALB/c mice enterocyte. Future work that can 
be carried out are further researches concerning whether these bacteria have an ability to inhibit 
adherence of other pathogen bacteria. More over, searching of cell wall adhesin of 
Bifidobacterium sp that can be used as a replacement of life probiotic bacteria is also a great 
interest of research to be carried out.  
 








Diarrhea is a disease characterized by a 
frequent increase of defecation (> 3 time/day) 
followed by changes of stools concistence, 
with/without gross blood and/or mucus. 
Diarrhea, up to the recent year remains a cause 
of high morbidity and mortality worldwide, 
especially in developing countries including 
Indonesia. Therefore, research concerning of 
management, prevention, and medication of the 
disease have been continually improved. WHO 
indicates that 4 billion cases occured worldwide 
during the years of 2000. Of these, 2.2 million 
were killed, whithin the most are children under 
5 years.1,2 In Indonesia, the morbidity rate of 
accute diarrhea are in the range of 200-400 cases 
per 1000 people per year. Of the most, 70-80% 
  
are children under 5 years. This group is 
experiencing diarrhea more than once per year. 
A part of this patient (1-2%) will be ended with 
dehydration and if there is no sufficient aid, 50-
60% of them could be died.1 
It was reported that the main cause of 
diarrhea dominated by enteropathogenic 
bacteria, including E. coli diarrheagenic 
involving ETEC and EPEC, Salmonella spp., 
Shigella spp., and Vibrio spp.3 Diarrhea caused 
by S. typhi were initiated by adherence of 
Salmonella typhi. This adhesion induces 
neutrophile transepithelial migration and villi 
entherocyte damage followed by membrane 
destruction on the site of addhesion. This 
damaging membrane subsequentially followed 
by endocytosis and internalization.  
It was well established that there are 
much more bacteria including diarrhea bacteria 
are resitance towards antibacterial.4,5 This 
condition has endorsed researches for 
establishing research to obtain an alternative 
cure to replace antibacterial that has already 
used clinically. Obtaining an agent that can 
affect or protect bacteria adherence is one of 
researhers strategy to overcome this situation. 
These kind of agents are known as anti-
adhesion. Other strategics are obtaining vaccine 
for diarrhea. Anti-adhesion agents are not 
bactericide or antibiotic, therefore, their 
propagation and occurrence for therapy will not 
leading to resistence.5,6 
 




Two research designs were 
employed, i.e explorative and true experi 
mental. Explorative was carried out to 
explore isolation and characterization of 
Bifidobacterium isolated from infants feces. 
Experimental study with Randomized 
Posttest-Only Control Group Design was 
employed to obtain inhibition ability of 
Bifidobacterium towards adhesion of 




Isolation of Bifidobacterium from infants 
feces 
 Isolation of Bifidobacterium from 
infants feces was carried out following 
Beeren, (1990) in Hadadji.7  About 1 g of 
infants feces was placed on a flask added 
with 9 mL NaCl (0.9%) containing 0.2 % 
cystein-HCl. This suspension was then 
homogenized for 2 minutes. Around 0.1 mL 
of this suspension was inoculated on MRS 
broth media. All plates were then 
anaerobically incubated using oxoid gas jar  
at temperature of 37 0C with 5 % CO2 for 
18-24 h. The Bifidobacterium obtained was 
then separated using solid MRS broth 
media. The clonal was then selected and 
indentified for further treatment. 
 
Isolation of Balb/c mice enterocyte  
Enterocyte isolation was carried out 
based on Weisler method taken from 
Nagayama.8 An healthy BALB/c mice age 
of 3 months was collected and treated for 
this experiment. Mice was killed using 
chloroform and resected. The intestine was 
taken out, cleaned and cut into 5 cm. Lumen 
intestine was then resected and cleaned 
using PBS solution containing dithiotreitol 1 
mM. The lumen was immersed on a solution 
containing of 1.5 mM KCl; 9.6 mM NaCl; 
2.7 mM Na-citrate; 8 mM KH2PO4 and 5.6 
mM Na2PO4, pH 7.3 and placed on water 
bath at temperature of 37 0C, and shaked for 
30 minutes. All solution was drained and 
replaced with PBS with pH of 7.4 containing 
1.5 mM EDTA and 0.5 mM dithiothreitol. 
Intestine tissues were shaked on water bath 
within temperature of 37 0C for 20 minutes. 
Solution was drained and the intestine was 
cleaned using PBS pH. Of 7.4 by 
centrifugation at 1000 rpm, at temperature 
of 40C for 5 minutes. The cleansing was 
carried out three times and suspended on 
PBS pH of 7.4 and shaked. Solution 
containing enterocyte characterized by cloud 
  
filtrate was taken using sterilized pippetes 
and store on steril tube, counted using 
leucocyte counting chamber and made up 
the concentration of 108 enterocyte/mL. 
 
Adhesion test of Bifidobacterium on 
enterocyte  
Nagayama method was employed for 
testing of Bifidobacterium adhesion on 
enterocyte.8 A number of 100 L of the 
Bifidobacterium suspension with concen 
tration of 108 cells/ml mixed with 100 L 
enterocyte cells of 108 cells/mL. The 
mixture was then incubated on shaker water 
bath and shaked at temperature of 370C for 
30 minutes. Cells were collected by 
centrifugation at 3000 rpm for 2 minutes. 
The precipitate was then collected for sweft 
preparate and gram staining. The preparate 
was observed under microscope with 1000 




Isolation of Bifidobacterium from Infants 
feces 
Isolation of Bifidobacterium from infant feces 
was carried out following Beeren, (1990) in 
Hadadji.7  Fecal suspension on NaCl solution 
with cystein-HCl was inoculated on broth media. 
The grown Bifidobacteria were separated using 
solid broth media. The clonal growth were then 
selected for identification (Figure1).  
 
Enterocyte Isolation 
Enterocyte isolation was carried out 
on the basis of Weisler method in 
Nagayama.8  
 
Adhesion of Bifidobacterium sp on 
Enterocyte 
Nagayama method was employed to 
observed adhesion of Bifidobacterium on 
enterocyte (Figure 2 and Table 1).8 Adhesion 
indices of Bifidobacterium sp on enterocyte 
were listed on Table 1. In this experiment, 
adhesion of Salmonella typhi on enterocyte was 
also performed. The result was drawn on Figure 
3.  
 
Inhibition test of Bifidobacterium towards 
Adhesion of Salmonella typhi on 
enterocyte  
 
Inhibition test of Bifidobacterium sp 
towards Salmonella typhi on enterocyte was 








Figure 1 Bifidobacterium sp isolated from infants feces 






Figure 2 Adhesion of bifidobacterium on enterocyte, 
bifidobacterium            enterocyte 







Figure 3 Adhesion of Salmonella typhi  on enterocyte,        S. typhi 





Figure 4 Inhibition of Bifidobacterium sp towards adhesion of 
Salmonella typhi on enterocyte 
Bifidobacterium             Salmonella typhi 
Interaction between Bifidobacterium with 







Table 1 Adhesion indices of Bifidobacterium sp on enterocyte  
 













2 1900 19 
3 1800 18 
4 2100 21 
5 2000 20 
6 1900 19 







In this experiment, bacteria isolated 
from infant feces are Bifidobacterium sp. 
This can be seen clearly from the 
characteristic of the bacteria as a short rod 
with Y and V shape (Figure 1). 
Bifidobacterium was initially discovered on 
the year of 1889 by Tissier, a researcher 
from Pasteur Institute French. It was 
obtained that the bacteria are a gram 
positive, anaerobe, short rod pleomorphism 
of Y and V shape, without spora, and 
originally named Bacillus bifidus communis 
and categorize into Lactobacillus and named 
as L. Bifidus.9-12 Then, in 1960 these bacteria 
were categorize into a special genus known 
as Bifidobacterium, characterized by their 
ability to produce lactate and acetic acids 
from glucose. Compotition of guanine and 
sitosine DNA of the bacteria are between 54 
and 67% per molecule, and the bacteria are 
sacarolityc.9-12  
 
Adhesion of Bifidobacterium sp on Mice 
Enterocyte  
The adhesion of Bifidobacterium sp 
on enterocyte mice was carried out to 
evaluate the ability of the bacteria to adhere 
on mice enterocyte. It can be seen from 
Figure 4.3, that the adhesion model of 
Bifidobacterium sp on enterocyte is diffuse 
adhesion. This model was marked by the 
bacteria are homogenously spread out on 
cell surface. It was known that there are 
three types of adhesion model, namely, 1) 
localized adherence, 2) aggregative 
adherence, and 3) diffuse adherence.13,14 
Localized adhesion was characterized by 
grouping bacteria colonization on the 
receptor cell surface. Moreover, aggregative 
adherenece was marked by stacked-brick 
model of bacteria adherence both in tissue 
culture and on the base of object glass. In 
addition, for the last adhesion model was 
characterized by the adhesion of the bacteria 
are hogenously spread out on the cell 
surface not on the surface of object glass.15  
Bifidobacterium on their comensal 
function should have an ability to interact 
with intestitinal epithelial cells and inducing 
fragment product that trigered and activated 
the cells. This condition was proven in this 
research. The interaction induces secretion 
of IL-6 and IL-10. TLR is playing an 
important role during these interaction and 
induction.16 There are four important things 
concerning of induction of intestinal 
  
immune response caused by Bifidobacterium 
adhesion, namely: (i) their interaction to 
epithelial cells, (ii) bacteria pathway of 
internalization on intestinal track, (iii) signal 
induction on intestinal immune cells to 
enhance cytokine production and appro 
priate producing cells, and (iv) improvement 
of IgA-producing cells on other mucosal 
cells, i.e. bronchus and mammary 
glands.16,17 
On the other hand, concerning of 
Salmonella typhi adhesion on mice 
enterocyte as depicted on Figure 4, adhesion 
models observed is localized adhesion 
indicated by rod shape of  Salmonella typhi 
adherence on enterocyte receptor. There 
should be an exposure and adherence of 
Salmonella typhi to enterocyte before 
invation of the bacteria as indicated on 
Figure 4. Adhesion of Salmonella typhi is a 
prerequisite for colonization and infection in 
gastrointestinal tract and becoming a major 
factor for occurence of invation and 
secretion of infection factors.18,19 
GIT mucosal surfaces are known to 
be the widest area of the human body, i.e. 
200-300 m2 that can be exposed with 
external environment. The content of the 
GIT mucosal are epithelial cells, immune 
cells, and inhabitance of natural 
microorganism.20 Adhesion ability of 
Salmonella typhi on enterocyte is the first 
step of infection, therefore, the bacteria can 
affect and explore the presence signal after 
adherence and then secreting virulence 
factors.18,21 
Disturbance of host natural activities 
leads to entrance of Salmonella typhi into 
epithelial barrier.22 Host cytosceleton is 
taken by enteric microbial pathogens, 
including Salmonella typhi as a media 
during cells penetration. In other words, this 
cytosceleton was exploited by the pathogen 
for entry site into the cells,  move along and 
intra cells or rebuild the vacuola which leads 
to protection and survival of the bacteria.23  
 It can be seen from Figure 4, that the 
presence of Bifidobacterium sp inhibited 
adhesion of Salmonella typhi on enterocyte. 
Meanwhile, as can be seen on Figure 3, 
Salmonella typhi itself has an ability to 
adhere on enterocyte, proven by its index 
adhesion of 1504 compare to about 1950 for 
Bifidobacterium. There are also interaction 
or competition between these two bacteria 
on enterocyte as indicated on the same 
figure. Bifidobacterium sp adhesion ability 
on enterocyte is consider to become a self 
difence  towards pathogen on GIT. The 
adherence of Bifidobacterium sp is also play 
an important role for competition adhesion 
site and nutrient with pathogen. Adhesion is 
also allowing Bifidobacterium sp to produce 
antimicrobial compounds and nutrient 
metabolism to produce volatile fatty acids 
and bile salt metabolits and leading to 
inapproriate environment for pathogen. 
Adhesion of Bifidobacterium on enterocyte 
can be consider as protection of intestinal 
mucosa and giving a steric hindrance effect, 
therefore, pathogen bacteria can not contact 
to intestinal mucosa. This phenomena is 
known as competition exclution effect.18  
This research is in line with Moroni 
finding, they found that there was adhesion 
of B. thermophilum sp. infantis RBL67 and 
B. thermacidophilum sp. suis strain RBL68 
and RBL70 on enterocyte cells.24 Adhesion 
ability of Bifidobacterium strain RBL67 and 
RBL70 were found bigger compare to 
adhesion of bifidum RBL71 which is 
reported before having the highest 
adhesion25 as well as for B. pseudolongum 
ATCC 25526.26 On the other hands, 
adhesion of B. thermacidophilum sp suis 
strain RBL68 was found comparable to B. 
bifidum RBL71. All Bifiobacteria strain 
tested were not invading the ephitelial cell, 
therefore, Bifidobacterium is included as 
non-invasive bacteria.  
  
CONCLUSSION AND FUTURE 
WORKS 
Conclussion 
1. Bacteria isolated from infants feces were 
exactly Bifidobacterium sp as indicated 
by their short rod like and V and Y shape. 
2. Bifidobacterium sp isolated from infants 
feces has an ability to inhibit adhesion of 
Salmonella typhi on mice enterocyte. 
 
Future Works 
1. Further researchs concerning of 
extraction of cell wall adhesin proteins of 
Bifidobacterium sp need to be carried 
out. 
2. Any further researchs should be carried 
out in term of commercially use of these 
adhesin proteins  including synthesis, 
production, and marketing, therefore it 
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